Status:
UNKNOWN
Attentional Impairment in People With Epilepsy
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Brief Summary
Epilepsy is one of the most common chronic neurological conditions.It leads to cognitive impairment in 20-50% of patients with a structural form. In comparison with seizures, these cognitive disorder...
Eligibility Criteria
Inclusion
- Patients:
- Patient with epilepsy, according to Fisher et al. (2005).
- Patient with written informed consent
- affiliation to a social security regime is compulsory
- Individuals who have received full information about the organization of the research and have not objected to their participation and the use of their data.
- Patient 18 years of age and older
- Normal controls:
- Individuals who have received full information about the organization of the research and have not objected to their participation and the use of their data.
- People 18 years of age and older
- People with no neurological and/or psychiatric history
Exclusion
- for patients: with another progressive neurological condition for all People of full age who are subject to a legal protection measure or who are unable to express their consent People deprived of their liberty by a judicial or administrative decision People who regularly use psychoactive substances (cannabis, alcohol...)
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
272 Patients enrolled
Trial Details
Trial ID
NCT04379128
Start Date
May 1 2020
End Date
August 1 2025
Last Update
May 7 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.